Application of second and third generation sequencing in pharmacogenetics

Summary

Application of second and third generation sequencing in pharmacogenetics is a doctoral thesis^[1].

Key Facts

• Application of second and third generation sequencing in pharmacogenetics authored Yusmiati Liau^[2].
• Application of second and third generation sequencing in pharmacogenetics's instance of is recorded as doctoral thesis^[3].
• Application of second and third generation sequencing in pharmacogenetics's publisher is recorded as OUR Archive^[4].
• Application of second and third generation sequencing in pharmacogenetics's language of work or name is recorded as English^[5].
• Application of second and third generation sequencing in pharmacogenetics's country of origin is recorded as New Zealand^[6].
• Application of second and third generation sequencing in pharmacogenetics's publication date is recorded as +2020-00-00T00:00:00Z^[7].
• Application of second and third generation sequencing in pharmacogenetics's main subject is recorded as nanopore sequencing^[8].
• Application of second and third generation sequencing in pharmacogenetics's main subject is recorded as DNA methylation^[9].
• Application of second and third generation sequencing in pharmacogenetics's main subject is recorded as pharmacogenetics^[10].
• Application of second and third generation sequencing in pharmacogenetics's work available at URL is recorded as https://ourarchive.otago.ac.nz/handle/10523/10094^[11].
• Application of second and third generation sequencing in pharmacogenetics's Handle ID is recorded as 10523/10094^[12].
• Application of second and third generation sequencing in pharmacogenetics's title is recorded as Application of second and third generation sequencing in pharmacogenetics^[13].
• Application of second and third generation sequencing in pharmacogenetics's copyright holder is recorded as Yusmiati Liau^[14].
• Application of second and third generation sequencing in pharmacogenetics's thesis submitted to is recorded as University of Otago^[15].
• Application of second and third generation sequencing in pharmacogenetics's on focus list of Wikimedia project is recorded as NZThesisProject^[16].
• Application of second and third generation sequencing in pharmacogenetics's copyright status is recorded as copyrighted^[17].
• Application of second and third generation sequencing in pharmacogenetics's thesis committee member is recorded as Simran Maggo^[18].
• Application of second and third generation sequencing in pharmacogenetics's thesis committee member is recorded as Martin Kennedy^[19].
• Application of second and third generation sequencing in pharmacogenetics's thesis committee member is recorded as Simone Cree^[20].
• Application of second and third generation sequencing in pharmacogenetics's thesis committee member is recorded as John Pearson^[21].

Body

Designation and Status

Application of second and third generation sequencing in pharmacogenetics's instance of is recorded as doctoral thesis^[3].